KR20050050115A - 유두종바이러스의 2종 이상의 비구조적 초기 단백질을암호화하는 dna 백신 - Google Patents

유두종바이러스의 2종 이상의 비구조적 초기 단백질을암호화하는 dna 백신 Download PDF

Info

Publication number
KR20050050115A
KR20050050115A KR1020057005806A KR20057005806A KR20050050115A KR 20050050115 A KR20050050115 A KR 20050050115A KR 1020057005806 A KR1020057005806 A KR 1020057005806A KR 20057005806 A KR20057005806 A KR 20057005806A KR 20050050115 A KR20050050115 A KR 20050050115A
Authority
KR
South Korea
Prior art keywords
ser
thr
leu
val
glu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
KR1020057005806A
Other languages
English (en)
Korean (ko)
Inventor
게랄드 웨인 고프
크리스토퍼 마이클 로버츠
Original Assignee
글락소 그룹 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 글락소 그룹 리미티드 filed Critical 글락소 그룹 리미티드
Publication of KR20050050115A publication Critical patent/KR20050050115A/ko
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/01DNA viruses
    • C07K14/025Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/20011Papillomaviridae
    • C12N2710/20022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Mycology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020057005806A 2002-10-03 2003-10-01 유두종바이러스의 2종 이상의 비구조적 초기 단백질을암호화하는 dna 백신 Abandoned KR20050050115A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0222953.2 2002-10-03
GBGB0222953.2A GB0222953D0 (en) 2002-10-03 2002-10-03 Novel Compounds

Publications (1)

Publication Number Publication Date
KR20050050115A true KR20050050115A (ko) 2005-05-27

Family

ID=9945247

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020057005806A Abandoned KR20050050115A (ko) 2002-10-03 2003-10-01 유두종바이러스의 2종 이상의 비구조적 초기 단백질을암호화하는 dna 백신

Country Status (21)

Country Link
US (2) US20060165713A1 (https=)
EP (1) EP1546191A2 (https=)
JP (1) JP2006516386A (https=)
KR (1) KR20050050115A (https=)
CN (1) CN100393878C (https=)
AR (1) AR041515A1 (https=)
AU (1) AU2003294672A1 (https=)
BR (1) BR0314986A (https=)
CA (1) CA2500093A1 (https=)
CO (1) CO5580837A2 (https=)
GB (1) GB0222953D0 (https=)
IS (1) IS7775A (https=)
MA (1) MA27474A1 (https=)
MX (1) MXPA05003558A (https=)
NO (1) NO20051561L (https=)
NZ (1) NZ539154A (https=)
PL (1) PL376534A1 (https=)
RU (1) RU2354701C2 (https=)
TW (1) TW200411055A (https=)
WO (1) WO2004031222A2 (https=)
ZA (1) ZA200503201B (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1753687A (zh) 2002-10-29 2006-03-29 科勒制药集团股份有限公司 Cpg寡核苷酸在治疗丙型肝炎病毒感染中的应用
CL2008000249A1 (es) * 2007-01-30 2008-05-30 Transgene Sa Uso de una molecula de acido nucleico que codifica al menos un polipeptido e2 del papilomavirus, un vector o una particula virica infecciosa que la comprenda para tratar una infeccion permanente por papilomavirus causada por al menos un papilomavirus
GB0710538D0 (en) * 2007-06-01 2007-07-11 Glaxo Group Ltd Vaccine
JP2013532971A (ja) * 2010-06-25 2013-08-22 バッシボディ アクスイェ セルスカプ ホモ二量体タンパク質コンストラクト
CN107001430A (zh) * 2014-10-24 2017-08-01 哈普威克斯有限责任公司 癌症和皮肤病变治疗
IL260030B2 (en) 2016-01-08 2025-12-01 Nykode Therapeutics ASA Therapeutic anticancer neoepitope vaccine
CA3023022A1 (en) * 2016-05-04 2017-11-09 Transgene Sa Combination therapy with cpg tlr9 ligand
JP2023550480A (ja) * 2020-11-25 2023-12-01 プレシゲン,インコーポレイテッド ヒト乳頭腫ウイルスワクチンおよびhpv関連疾患のための同ワクチンの使用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN443995A0 (en) * 1995-07-27 1995-08-17 Csl Limited Papillomavirus polyprotein
HK1056195B (en) * 2000-07-21 2007-06-22 Glaxo Group Limited Codon-optimized papilloma virus sequences
GB0017990D0 (en) * 2000-07-21 2000-09-13 Glaxo Group Ltd Papilloma virus sequences

Also Published As

Publication number Publication date
TW200411055A (en) 2004-07-01
MXPA05003558A (es) 2005-06-03
AR041515A1 (es) 2005-05-18
WO2004031222A2 (en) 2004-04-15
US20060165713A1 (en) 2006-07-27
JP2006516386A (ja) 2006-07-06
BR0314986A (pt) 2005-08-09
NO20051561L (no) 2005-06-02
CN1720261A (zh) 2006-01-11
PL376534A1 (pl) 2006-01-09
IS7775A (is) 2005-03-29
US20070264283A1 (en) 2007-11-15
CA2500093A1 (en) 2004-04-15
CO5580837A2 (es) 2005-11-30
MA27474A1 (fr) 2005-08-01
CN100393878C (zh) 2008-06-11
WO2004031222A3 (en) 2004-08-19
RU2354701C2 (ru) 2009-05-10
RU2005109155A (ru) 2006-03-10
NO20051561D0 (no) 2005-03-23
GB0222953D0 (en) 2002-11-13
EP1546191A2 (en) 2005-06-29
ZA200503201B (en) 2006-06-28
NZ539154A (en) 2007-05-31
AU2003294672A1 (en) 2004-04-23

Similar Documents

Publication Publication Date Title
Liu et al. Polynucleotide viral vaccines: codon optimisation and ubiquitin conjugation enhances prophylactic and therapeutic efficacy
KR100874552B1 (ko) 코돈-최적화 파필로마 바이러스 서열
TWI731300B (zh) 一種新型多價hpv 疫苗成份
CA2305683C (en) Immunogenic peptides from the hpv e7 protein
US20120087937A1 (en) Novel compositions
US20100158930A1 (en) Hpv antigen fusion protein vaccine compositions and uses thereof
US20010006639A1 (en) Immunogenic peptides from the HPV E7 protein
KR102715320B1 (ko) 신형 hpv 치료용 핵산 백신
US20070264283A1 (en) Vaccine
EP0561885B1 (en) Subunit papillomavirus vaccine
US7132262B2 (en) Papilloma virus sequences
WO2008145745A1 (en) Vaccine against hpv
Brinkman et al. The efficacy of a DNA vaccine containing inserted and replicated regions of the E7 gene for treatment of HPV-16 induced tumors
EP1427443A1 (en) Vaccine using papilloma virus e proteins delivered by viral vector
KR100904844B1 (ko) 인유두종 바이러스(hpv)유전자를 포함하는자궁경부암의 치료 또는 예방용 dna 백신
US10329328B2 (en) HPV-related fusion protein and applications thereof
WO2025030015A1 (en) Cmv-based human papillomavirus vaccines
AU660954B2 (en) Subunit papillomavirus vaccine and peptides for use therein
Kwak Development of prophylactic human papillomavirus vaccines

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20050402

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20081001

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20101022

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20110215

NORF Unpaid initial registration fee
PC1904 Unpaid initial registration fee